123 related articles for article (PubMed ID: 23257520)
1. Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease.
Hirohata S; Kikuchi H
Intern Med; 2012; 51(24):3359-65. PubMed ID: 23257520
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.
Hirohata S; Isshi K; Oguchi H; Ohse T; Haraoka H; Takeuchi A; Hashimoto T
Clin Immunol Immunopathol; 1997 Jan; 82(1):12-7. PubMed ID: 9000037
[TBL] [Abstract][Full Text] [Related]
3. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases.
Saruhan-Direskeneli G; Yentür SP; Akman-Demir G; Işik N; Serdaroğlu P
J Neuroimmunol; 2003 Dec; 145(1-2):127-34. PubMed ID: 14644038
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Behçet's disease.
Kikuchi H; Takayama M; Hirohata S
J Neurol Sci; 2014 Feb; 337(1-2):80-5. PubMed ID: 24289890
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome.
Akman-Demir G; Tüzün E; Içöz S; Yeşilot N; Yentür SP; Kürtüncü M; Mutlu M; Saruhan-Direskeneli G
Cytokine; 2008 Dec; 44(3):373-6. PubMed ID: 19010690
[TBL] [Abstract][Full Text] [Related]
6. [Chronic Progressive Neuro-Behçet's Disease].
Hirohata S
Brain Nerve; 2021 May; 73(5):568-575. PubMed ID: 34006690
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid beta(2)-microglobulin in neuro-Behçet's syndrome.
Kawai M; Hirohata S
J Neurol Sci; 2000 Oct; 179(S 1-2):132-9. PubMed ID: 11054497
[TBL] [Abstract][Full Text] [Related]
8. CSF levels of cytokines in neuro-Behçet's disease.
Borhani Haghighi A; Ittehadi H; Nikseresht AR; Rahmati J; Poorjahromi SG; Pourabbas B; Nazarinia MA; Habibagahi Z; Fattahi MJ; Ghaderi A
Clin Neurol Neurosurg; 2009 Jul; 111(6):507-10. PubMed ID: 19303205
[TBL] [Abstract][Full Text] [Related]
9. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
10. Effect of infliximab in progressive neuro-Behçet's syndrome.
Kikuchi H; Aramaki K; Hirohata S
J Neurol Sci; 2008 Sep; 272(1-2):99-105. PubMed ID: 18550081
[TBL] [Abstract][Full Text] [Related]
11. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
Matsui T; Ishida T; Tono T; Yoshida T; Sato S; Hirohata S
Mod Rheumatol; 2010 Dec; 20(6):621-6. PubMed ID: 20617356
[TBL] [Abstract][Full Text] [Related]
12. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
13. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
[TBL] [Abstract][Full Text] [Related]
14. [Central nervous system involvement in Behçet's disease].
Hirohata S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1147-9. PubMed ID: 12235822
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease.
Hamzaoui K; Maître B; Hamzaoui A
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S52-7. PubMed ID: 19796534
[TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Behçet's syndrome.
Wang CR; Chuang CY; Chen CY
Clin Exp Rheumatol; 1992; 10(6):599-602. PubMed ID: 1483312
[TBL] [Abstract][Full Text] [Related]
17. [A case of chronic progressive neuro-Behçet disease with extensive cerebral atrophy and elevated CSF IL-6 activity treated with infliximab].
Hamada K; Takei R; Sakiyama Y; Moriyama H; Hashiguchi A; Takashima H
Rinsho Shinkeigaku; 2018 Jan; 58(1):30-34. PubMed ID: 29269695
[TBL] [Abstract][Full Text] [Related]
18. Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.
Hirohata S; Suda H; Hashimoto T
J Neurol Sci; 1998 Aug; 159(2):181-5. PubMed ID: 9741405
[TBL] [Abstract][Full Text] [Related]
19. Significance of CSF total neopterin and biopterin in inflammatory neurological diseases.
Furukawa Y; Nishi K; Kondo T; Tanabe K; Mizuno Y
J Neurol Sci; 1992 Aug; 111(1):65-72. PubMed ID: 1402999
[TBL] [Abstract][Full Text] [Related]
20. [Central nervous system involvement in rheumatic diseases].
Hirohata S
Nihon Rinsho; 1999 Feb; 57(2):409-12. PubMed ID: 10078015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
